Created at Source Raw Value Validated value
June 25, 2024, noon usa

inclusion criteria: 1. adult patients \> 18 years 2. confirmed diagnosis of covid-19 or high clinical suspicion according to current criteria. 3. diagnosis prior to admission of dm2. 4. patients who provide their informed consent to participate in the study

inclusion criteria: 1. adult patients \> 18 years 2. confirmed diagnosis of covid-19 or high clinical suspicion according to current criteria. 3. diagnosis prior to admission of dm2. 4. patients who provide their informed consent to participate in the study

Nov. 16, 2021, 6:30 p.m. usa

inclusion criteria: adult patients > 18 years confirmed diagnosis of covid-19 or high clinical suspicion according to current criteria. diagnosis prior to admission of dm2. patients who provide their informed consent to participate in the study

inclusion criteria: adult patients > 18 years confirmed diagnosis of covid-19 or high clinical suspicion according to current criteria. diagnosis prior to admission of dm2. patients who provide their informed consent to participate in the study

Oct. 26, 2020, 11:31 p.m. usa

inclusion criteria: 1. adult patients > 18 years 2. confirmed diagnosis of covid-19 or high clinical suspicion according to current criteria. 3. diagnosis prior to admission of dm2. 4. patients who provide their informed consent to participate in the study

inclusion criteria: 1. adult patients > 18 years 2. confirmed diagnosis of covid-19 or high clinical suspicion according to current criteria. 3. diagnosis prior to admission of dm2. 4. patients who provide their informed consent to participate in the study